Determinants of migraine-specific quality of life

Cephalalgia

Volumn 22, Issue 8, 2002, Pages 680-685

  Santanello, Nancy C ^a   Davies, G ^a   Allen, C ^a   Kramer, M ^a   Lipton, R ^b,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Innovative Medical Research   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Functional ability; Migraine; Quality of life; Recurrence; Rizatriptan

Indexed keywords

PLACEBO; RIZATRIPTAN; SEROTONIN AGONIST; TRIAZOLE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EXPERIENCE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OUTCOMES RESEARCH; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK BENEFIT ANALYSIS; SCORING SYSTEM; MULTICENTER STUDY; PATHOPHYSIOLOGY; TIME;

ADULT; HUMANS; MIGRAINE DISORDERS; MULTICENTER STUDIES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SEROTONIN AGONISTS; TIME FACTORS; TRIAZOLES; TRYPTAMINES;

EID: 0036780470     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2002.00435.x     Document Type: Article

References (21)

1. Dahlof CGH, Solomon GD. The burden of migraine to the individual sufferer: a review. Eur J Neurol 1998; 5:525-33.
2. Abu AI, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ 1994; 309:765-9.
3. Osterhaus JT, Townsend RJ, Gandek B, Ware JE. Measuring the functional status and well-being of patients with migraine headache. Headache 1994; 34:337-43.
4. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267:64-9.
5. Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American migraine study. Cephalalgia 1996; 16:231-8.
6. Dowson A, Jagger S. The UK migraine patient survey: quality of life and treatment. Curr Med Res Opin 1999; 15:241-53.
7. Smith R. Impact of migraine on the family. Headache 1998; 38:423-6.
8. Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 1999; 53:988-94.
9. Edmeads J, Findlay H, Tugwell P, Pryse PW, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 1993; 20:131-7.
10. Hu H, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States - disability and economic costs, a population based approach. Arch Intern Med 1999; 159:813-8.
11. Solomon GD, Skobieranda FG, Genzen JR. Quality of life assessment among migraine patients treated with sumatriptan. Headache 1995; 35:449-54.
12. Jhingran P, Cady RK, Rubino J, Miller D, Grice RB, Gutterman DL. Improvements in health-related quality of life with sumatriptan treatment for migraine. J Fam Pract 1996; 42:36-42.
13. Mushet GR, Miller D, Clements B, Pait G, Gutterman DL. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine. Headache 1996; 36:137-43.
14. Hartmaier SL, Santanello NC, Epstein RS, Silberstein SD. Development of a brief 24-hour migraine-specific quality of life questionnaire. Headache 1995; 35:320-9.
15. Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD. Validation of a new quality of life questionnaire for acute migraine headache. Headache 1995; 35:330-7.
16. Santanello NC, Polis AB, Hartmaier SL, Kramer MS, Block GA, Silberstein SD. Improvement in migraine-specific quality of life in a clinical trial of rizatriptan. Cephalalgia 1997; 17:867-72.
17. Kramer MS, MatzuraWolfe D, Polis A, Getson A, Amaraneni PG, Solbach MP et al. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Neurology 1998; 51:773-81.
18. Tfelt HP, Teall J, Rodriguez F, Giacovazzo M, Paz J, Malbecq W et al. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Headache 1998; 38:748-55.
19. Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy. Headache 1999; 39:S20-S26.
20. Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000; 20:554-60.
21. Santanello NC, Polis AB, Hartmaier SL, Kramer MS, Block GA, Silberstein SD. Improvement in migraine-specific quality of life in a clinical trial of rizatriptan. Cephalalgia 1997; 17:867-72.